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Department of Bioengineering, University of Washington, Seattle, WashingtonABSTRACT Transmissible spongiform encephalopathies, or prion diseases, are caused by misfolding and aggregation of
the prion protein PrP. Conversion from the normal cellular form (PrPC) or recombinant PrP (recPrP) to a misfolded form is
pH-sensitive, in that misfolding and aggregation occur more readily at lower pH. To gain more insight into the influence of pH
on the dynamics of PrP and its potential to misfold, we performed extensive molecular-dynamics simulations of the recombinant
PrP protein (residues 90–230) in water at three different pH regimes: neutral (or cytoplasmic) pH (~7.4), middle (or endosomal)
pH (~5), and low pH (<4). We present five different simulations of 50 ns each for each pH regime, amounting to a total of 750 ns
of simulation time. A detailed analysis and comparison with experiment validate the simulations and lead to new insights into the
mechanism of pH-induced misfolding. The mobility of the globular domain increases with decreasing pH, through displacement
of the first helix and instability of the hydrophobic core. At middle pH, conversion to a misfolded (PrPSc-like) conformation
is observed. The observed changes in conformation and stability are consistent with experimental data and thus provide a
molecular basis for the initial steps in the misfolding process.INTRODUCTIONTransmissible spongiform encephalopathies (TSEs), or
prion diseases, are fatal neurodegenerative disorders that
occur in a range of mammals. These disorders include
Creutzfeldt-Jakob disease (CJD) and kuru in humans, scrapie
in sheep, bovine spongiform encephalopathy in cattle, and
chronic wasting disease in cervids. In humans, TSEs can
arise spontaneously, via inheritance of predisposing muta-
tions, or by infection (1,2). The disorders are characterized
by aggregates of the prion protein PrP that accumulate in
neuronal cells, although it is not yet clear what type of PrP
particle is neurotoxic (3,4). Misfolding and aggregation of
the normal cellular form of the prion protein (PrPC) to a
largely proteinase K resistant aggregate (PrPSc) is the central
event in the development of TSE diseases. Propagation of
PrPSc, which is relevant for spreading of disease within indi-
viduals as well as through cross-species infection, is believed
to occur through recruitment of PrPC by the PrPSc template.
An understanding of the location, circumstances, and mech-
anism of both the initial PrPC misfolding and the subsequent
propagation is of great importance for the detection, treat-
ment and prevention of TSE diseases.
Mature human PrP contains 208 residues (residues 23–
230; human numbering is used throughout), is attached to
a membrane with a glycosylphosphatidyl-inositol (GPI)
anchor, and can be glycosylated in two positions. The
N-terminal region (residues 23–127) is highly flexible
(5–8), and the C-terminal part (residues 128–228) is folded
and contains three a-helices (HA, HB, and HC) and a short,
two-stranded antiparallel b-sheet (S1 and S2; Fig. 1 A).Submitted June 30, 2010, and accepted for publication July 27, 2010.
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0006-3495/10/10/2289/10 $2.00Apart from an increase in b-sheet content (9–11), details
about how the PrP structure changes upon misfolding and
aggregation are not known. This is largely due to the diffi-
culty of obtaining detailed structural information for protein
aggregates, and the experimental challenges posed by
working with brain-derived PrP. Many studies have there-
fore been performed using recombinant PrP (recPrP), which
usually consists of residues 90–230/231 and lacks the GPI-
anchor and glycosylation. This fragment is relevant for
studying conversion of PrPC to PrPSc, as purification of
PrPSc aggregates most commonly results in PrP subunits
of residues ~90–230. The fragment includes regions that
are crucial for aggregation (residues 98–110 and 136–140)
(12), the neurotoxic peptide 106–126 (13,14), and the toxic
and infectious construct PrPSc106 (15).
About 85% of cases of fatal prion disease in humans are
sporadic forms of CJD for which no association with muta-
tions or exposure to TSE-infected material is evident. It is
therefore likely that PrPC can misfold spontaneously, but
such misfolding must be a rare event in vivo. PrPC mole-
cules located on the outer cellular membrane are regularly
taken into the cell through the endosomal pathway (16).
The pH environment in endosomes is relatively low
(pH ~5) (17), and it has been suggested that misfolding
of PrP in sporadic TSE disease occurs there (18–21).
Various in vitro studies have reported a relationship
between low pH and misfolding and aggregation of PrP
(22). In particular, significant conformational changes in
human recPrP occur between pH 6 and 4.4 (23), and
spontaneous fibril formation of human recPrP occur under
conditions of pH 4.0 and slow rotation (24). Furthermore,
the thermodynamic stability of PrP decreases significantly
when the pH is lowered from pH 7 to pH 4.8 (25) or
pH 4.5 (26).doi: 10.1016/j.bpj.2010.07.063
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FIGURE 1 Structure of human PrP 90–230. (A) Starting structure of
recombinant PrP used for the simulations, based on the NMR solution struc-
ture obtained at pH 4.5 (7). Secondary structure elements are labeled and
the side chains and surface of the residues in the hydrophobic core (51)
are shown. (B) The same structure as in panel A (but truncated), with all
His, Asp, and Glu residues in the globular domain shown and labeled.
(The flexible N-terminus contains His96 and His111 and no Asp or Glu
residues.)
2290 van der Kamp and DaggettDespite the destabilizing effects of lowpH, a previousNMR
study (26) indicated that there is little difference between the
global conformation of PrP at pH 7 and pH 4.5. It is possible,
however, that misfolded conformations were not detected in
that study due to a relatively small fraction and/or structural
diversity of misfolded conformations and aggregation.
Previousmolecular-dynamics (MD) studies by our group indi-
cate that low pH can promote conversion of PrP to amisfolded
form (27–30), which includes extension of the native b-sheet.
This misfolded form can be fit into a spiral protofibril, which
may represent the early aggregation phase of PrP (PrPSc) and
the infectious or neurotoxic particle (29,31).
Here, we expand upon previous studies and perform
extensive explicit-solvent MD simulations of wild-type
recPrP using three different setups representing three
different pH ranges. The simulations are significantly longer
(50 ns each) than those used in the vast majority of pub-
lished MD studies on PrP, and five separate simulations
were performed for each of the pH ranges to obtain more
comprehensive conformational sampling than is possible
through single MD trajectories. The total simulation time
amounts to 750 ns, or 0.75 ms. We analyze the differences
between neutral- and lower-pH regimes in detail and on
a large scale, which allows for the identification of general
structural and dynamical changes to human PrP caused by
a shift to lower pH. Furthermore, conformational changes
consistent with conversion are observed in one of the simu-
lations in the mildly acidic pH range, which is representative
of the pH used for in vitro conversion of recPrP (24) and the
pH of endocytic compartments (17). The mechanism of this
conformational change is described in detail.
METHODS
The starting structure for all simulations was based on human PrP at pH 4.5,
Protein Data Bank (PDB) code 1QLX (7). The missing flexible N-terminal
residues were modeled in accordance with nuclear Overhauser effectBiophysical Journal 99(7) 2289–2298(NOE) data and placed such that they were free to move in different
directions without biasing the simulations (Fig. 1). The resulting PrP struc-
ture (residues 90–230) was further prepared in three different ways to reflect
three different pH ranges: neutral (histidines neutral and other titratable side
chains charged, pH ~7–8), middle (all titratable side chains charged, pH ~5,
i.e., His protonated), and low (all titratable side chains protonated, i.e., Glu
and Asp protonated in addition to His, pH 3–4). At neutral pH, His144 was
protonated on Nd1 and all other histidines were protonated on N32.
Explicit solvent all-atom MD simulations were performed at 298 K with
in lucem molecular mechanics (ilmm) (32), employing the Levitt et al. (33)
force field and theF3Cwatermodel (34) and using previously described proto-
cols (35). Five simulations of 50 ns were performed at each pH range with
different starting velocities. The total simulation time therefore amounted to
750 ns. Structures were saved every 1 ps. Ca root mean-square deviation
(RMSD),Ca rootmean-squarefluctuation (RMSF), solvent-accessible surface
area (SASA) (36), DSSP (Define Secondary Structure of Proteins) (37), and
contact and NOE crosspeak analyses were performed with ilmm (32). NOE
data obtained for human E200K PrP (BMRB entry 4641) (38) were used.
Atom-atom contacts were classified as follows: salt bridge (carboxyl oxygen
(s) in contact with nitrogens of charged groups), hydrogen bond (donor-
hydrogen-acceptor angle > 135 and hydrogen-acceptor distance% 2.6 A˚),
and hydrophobic (CC distance between CHn groups% 5.4 A˚). A detailed
description of the methods used is available in the Supporting Material.
RESULTS AND DISCUSSION
Validation of simulation by comparison
with NOE restraints
To assess the overall agreement of the MD simulations
with experiment, we compared the results with the publicly
available NOE restraints for human PrP with the E200K
mutation, which is structurally very similar to WT PrP
(38). We first determined the expected level of agreement
by comparing the E200K restraints with theWTNMR struc-
tures for human PrP obtained at pH 4.5 and 7.0. The NMR
bundles (PDB codes 1QLZ and 1HJN) showed a NOE
restraint satisfaction of 90% for all NOEs and 79% for
long-range NOEs. Consequently, this is the expected corre-
spondence between WTand E200K. The structures sampled
from our MD simulations showed similar satisfaction: 91%,
91%, and 90% of the total NOEs, and 76%, 77%, and 75% of
the long-rangeNOEs for neutral, middle, and lowpH, respec-
tively. The overall simulation data are therefore in line with
the experimental NMR data, indicating that our simulations
sample experimentally relevant conformations. NOE
restraint satisfaction was further measured for the individual
trajectories as a function of simulation time (see Fig. S2). The
neutral-pH simulations did not show a significant decline in
satisfaction, whereas several middle- and low-pH simula-
tions (three each) did. Such a decline signifies a drift in
conformation away from the main structured ensemble, indi-
cating that conformational changes may be occurring.
Ca RMSD as an indicator of structural stability
The Ca RMSD of the structured portion of the protein (the
globular domain, residues 128–228) was used to monitor
the stability and occurrence of conformational changes in
that region (Fig. 2 A). The neutral-pH simulations showed
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FIGURE 2 Stability and flexibility of PrP in the three different pH regimes. (A) Ca RMSD of the globular domain (residues 128–228). (B) Ca RMSF of the
globular domain as calculated from 1 ns time windows throughout the trajectory and averaged over all five simulations for each pH regime. Vertical lines
indicate the standard deviation across the five simulations, and secondary structure elements are indicated in the horizontal bar. (C) The SASA of the hydro-
phobic core, calculated as the side-chain SASA of the following residues: 134, 137, 139, 141, 158, 161, 175, 176, 179, 180, 184, 198, 203, 205, 206, 209, 210,
and 213–215. For clarity, a windowed average over a period of 250 ps is shown in panels A and C.
pH-Induced Changes in the Prion Protein 2291only moderate changes in RMSD, whereas significant
differences occurred in several middle- and low-pH simula-
tions (particularly in middle-pH simulations 3, 4, and 5, and
low-pH simulations 2, 3, and 5). The changes were most
extreme in three low-pH simulations. Of interest, the
RMSD of the other two low-pH simulations stayed low, in
similarity to the neutral-pH simulations. This difference
indicates a relatively rare but large conformational change
happening in the low- and (to a lesser extent) middle-pH
simulations. Visual inspection revealed large movements
of HA in all simulations that reached Ca RMSD values >
3 A˚, and a comparison of specific RMSD matrices
confirmed that HA movement was the main contributor to
the increase in Ca RMSD (Fig. S4). Ca RMSD was also
measured for portions of HB and HC (linked by the disulfide
bond) that form a stable helical core of the prion protein(7,8,26) (Fig. S3). Apart from one outlier (neutral-pH simu-
lation 1), the Ca RMSD was ~1 A˚ in all simulations from 25
to 50 ns (see the Supporting Material). Experimental data
indicate a conformational change and a decrease in stability
with decreasing pH (23,25,26,40). Our simulations suggest
that this instability is primarily related to increased move-
ment outside the stable HB-HC core, in particular of HA.Backbone flexibility probed by Ca RMSF
The RMSFs of the Ca atoms were measured from average
structures calculated from 1 ns time windows throughout
the trajectory. This procedure minimizes the influence of
conformational changes on themagnitude of the fluctuations,
providing an overall indication of backbone mobility. The
flexibility of the N-terminal residues (residues 90–127) wasBiophysical Journal 99(7) 2289–2298
2292 van der Kamp and Daggettalways high and on par with the flexibility of loops in the
globular domain (Fig. S2). After residue 127 the Ca RMSF
dropped sharply, marking the start of the structured globular
domain. The CaRMSF for this domain was calculated based
on alignment of structures on residues 128–228 only, to avoid
the influence of the unstructured N-terminal domain on the
alignment and the subsequently calculated RMSF values
(Fig. 2 B).
Generally, the secondary structure elements showed the
lowest Ca RMSF values, and loops showed the highest.
This trend was not observed in the C-terminal portions of
HB and HC and the loop between HA and S2, in agreement
with hydrogen/deuterium exchange protection factors
(7,26). The loop also had a high backbone displacement in
the NMR bundles (7,26). For the C-terminal portion of
HC, there are many experimental indications of high flexi-
bility: residues 220–231 are considered partly disordered
in mouse PrP (41) and human PrP with the R220K mutation
(42) and NMR relaxation studies on hamster and mouse PrP
show fast picosecond timescale motions of the backbone
amides from residue 222 (8,43). The NMR studies also indi-
cated picosecond timescale motions in the loop between HB
and HC, subnanosecond flexibility in the loop preceding HAHis187
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Biophysical Journal 99(7) 2289–2298(residues 137–141), and slow motions in residues flanking
the unstructured loop between S2 and HB (8,43), which is
in line with the increased Ca RMSF we observed for these
loop regions.
The trend of flexibility was the same for simulations at the
three pH regimes. Differences in Ca RMSF mostly existed
in the loops between S1 and HA and between HB and
HC. Increased flexibility at low pH for residues 140–144
agrees with the reported pH sensitivity at the N-terminal
end of HA (44). At middle pH, residues 136–139 showed
higher flexibility. A marked increase in flexibility relative
to neutral pH was observed for the HB-HC loop at middle
and low pH. The different patterns of flexibility are related
to conformational differences in this loop (Fig. 3 C).Stability of secondary structure elements
In the majority of simulations, the three hydrogen bonds of
the native b-sheet were populated for at least 90% of the
time, but the population was decreased significantly for
one or more hydrogen bonds in some simulations. In the
fourth neutral-pH simulation, the hydrogen bond between
Met129 N and Tyr163 O broke after 7.7 ns of simulation.His187
Asp202
Phe198
Met206
et205
213
HC
HB
Middle
FIGURE 3 Main conformational
changes observed in the middle- and
low-pH simulations. (A) Helix A
throughout the neutral- (cyan), middle-
(orange, or yellow for simulation 5),
and low- (red) pH simulations. HA
conformations from all 15 simulations
are depicted at 2 ns intervals. Three
different views are shown, and for refer-
ence the starting structure is displayed
in gray. (B) Example of the (lack of)
hydrophobic packing of residues in the
loop connecting S1 and HA to residues
on HC. (Left) Starting structure. (Right)
Snapshot at 10 ns from low-pH simula-
tion 3. (C) Conformations of the HB-
HC loop and related residues. (Left)
Typical situation in the neutral-pH
simulations, with Phe198 interacting
with Met206. (Middle) Snapshots of
neutral- (cyan), middle- (orange), and
low- (red) pH simulations after 40 ns
of simulation. Simulation 1 at neutral
pH, an outlier, is shown in blue. (Right)
Typical situation after equilibration in
the middle-pH simulations: His187
forms a salt bridge with Asp202, pre-
venting Phe198 from returning to the
hydrophobic core. Please note that the
colors refer to the online figures.
pH-Induced Changes in the Prion Protein 2293The same hydrogen bond showed low population through-
out the fourth middle-pH simulation (42%) and during the
last 14 ns of the third middle-pH simulation (59%). In the
latter, the population of the Gly131-Val161 hydrogen bond
was also reduced (71% over the whole simulation). The
decreased stability of the native sheet in a number of simu-
lations may indicate that this is a weak spot in the PrP
structure, as was recently suggested in experimental and
theoretical studies (45,46). Changes in the native sheet
conformation may also be related to the slow (micro- to
millisecond) movement indicated by NMR relaxation
measurements (8,43). Cysteine-scanning, site-directed spin
labeling has shown that S2 is a pH-sensitive region (44).
None of the helices were lost in any of the simulations,
but the final turn of HA (residues 153–156) was labile. In
neutral-pH simulations, the turn formed a 310 helix for
19–30% of the time, whereas only two middle-pH simula-
tions showed significant periods of 310 helix (9% and 7%
of the time in simulations 3 and 5, respectively). The lack
of structure at middle pH compared with neutral pH is
consistent with the main conformational difference found
by NMR: at pH 7, residues 153–156 formed a 310 helix,
whereas the conformation was less ordered at pH 4.5
(7,26). Calzolai and Zahn (26) suggested that this difference
could be due to the repulsion of positive charges on His155
and Arg156 at lower pH, which is supported by our observa-
tion that the average distance between their side-chain
nitrogens was 2.1 A˚ longer in the middle-pH simulations
(from 10–50 ns). In the majority of the low-pH simulations
and the fifth simulation at the middle-pH regime, the final
turn of HA became fully a-helical. This change was not
observed in anyof the neutral-pH simulations andwas related
to displacement of HA, as discussed in the next section.
HB and HC were particularly stable around the disulfide
bond (Cys179-Cys214). The population of i/iþ4 main-
chain hydrogen bonds was generally >90% for residues
172–183 in HB and >85% for residues 200–224 in HC, in
line with hydrogen/deuterium exchange protection factors
(7,26). The population of hydrogen bonds in the C-terminal
part of HB (residues 184–195) decreased with pH: 89%,
86% and 73% for neutral, middle, and low pH, respectively
(outlier neutral-pH simulation 1 was not taken into account).
This trend may be influenced by protonation of His187 (26),
but protonation of Asp and Glu had a larger effect, for
example, through restructuring of the HB-HC loop in
response to protonation of Glu196. No trend with pH was
evident for hydrogen bonding in the C-terminal part of HC.Increased movement of HA
Significant changes in the positioning of HA occurred in the
middle- and low-pH simulations (Fig. 3 A, Fig. S4). Middle-
pH simulations 3 and 4 featured a shift of the N-terminal end
of HA downward. In low-pH simulations, the N-terminal
end swung away from HC (Fig. 3 A, Fig. S4), especiallyin the second (after 4.7 ns), third (after 39.9 ns), and fifth
(after 9.0 ns) simulations. A similar swing was observed
in the fifth middle-pH simulation (after 20.7 ns). This repo-
sitioning was accompanied by a significant loss of contacts
between HA and the rest of the globular domain, including
a hydrogen bond between Tyr149 and Asp202 (Table S1).
In line with the conformational changes observed at
middle and low pH, the tertiary contact region of HA was
found to be highly pH-sensitive in mouse recPrP, with
lowering of pH causing a marked increase in mobility
(44). In previous simulations, our group (27–30), as well
as Colacino et al. (47), observed an increase in mobility
and positional changes of HA at low pH. Further, unfolding
studies under high temperature, high pressure, or with dena-
turant indicated that HA and the preceding loop can rear-
range and become detached from the remainder of the
protein (48,49), and a partially misfolded conformation
with a similarly displaced HA helix was found in replica
exchange MD simulations (50). Together, these data suggest
that increased mobility and repositioning of HA in response
to a decrease in pH may be related to misfolding.Instability in the hydrophobic core: changes
in loop conformations
A core of interacting hydrophobic side chains can be defined
in the prion protein (51) (Fig. 1 A). The interactions in this
hydrophobic core may confer stability to the globular
domain of PrP. By measuring the solvent accessibility of
the side chains, we were able to assess the compactness of
the hydrophobic core (Fig. 2 C). Whereas the SASA in
neutral-pH simulations fluctuated around 350 A˚2 (with the
first simulation again being an outlier), values were higher
at middle pH, particularly for simulations 3 and 5, in which
they varied between 380 and 840 A˚2. Three low-pH simula-
tions (simulations 2, 3, and 5) displayed similar extreme
behavior. The large changes in solvent accessibility must
be related to conformational changes that expose hydro-
phobic surfaces. Such changes were detected experimen-
tally between pH 4.4 and 6 (23), and can be further
identified using our simulations.
The main cause of exposed hydrophobic surface in our
simulations was a change in conformation of the loop
between S1 and HA, particularly residues 137–141. In the
starting structure and at neutral pH, Pro137, Ile139, and
Phe141 interact with Met205, Val209, and Met213 on HC
(Fig. 3 B). The importance of these interactions for stability
is illustrated by the significant decrease in thermostability
(DDG ~3 kcal/mole) of M205A and M213A mutant PrP
(52). The average number of hydrophobic atom-atom
contacts between 137,139,141 and 205,209,213 at neutral
pH was lower than in the starting structure (~25 vs. 45),
illustrating the dynamic nature of the loop. In middle- and
low-pH simulations with a large increase in solvent accessi-
bility of the hydrophobic core (>600 A˚2), however, contactsBiophysical Journal 99(7) 2289–2298
2294 van der Kamp and Daggettwere dramatically reduced. Interestingly, the sensitivity to
pressure of Ile139 and Phe141 in human PrP suggests
local conformational freedom and indicates that this region
may be a starting point for aggregation (53), as we proposed
previously based on simulation and modeling (28,29,31,54).
Our current simulations show that the loss of contacts and
related exposure of hydrophobic surface precedes outward
displacement of HA.
A further cause of increased exposure of hydrophobic
surface area at middle and low pH is the positioning of
Phe198, which is located in the loop between HB and HC
(residues 194–199). In the starting structure and in simula-
tions at neutral pH, the Phe198 side chain was placed
between the helices, where it formed many hydrophobic
contacts, particularly with Met206. At middle and low pH,
the loop changed conformation and Phe198 swung out into
solvent (Fig. 3 C). In two low-pH simulations, Phe198
partially returned to its original position, whereas this never
happened at middle pH. Crystal structures of human PrP
indicate that the HB-HC loop has increased conformational
freedom: it forms the hinge in domain-swapped dimers
(55,56) and it is part of the most disordered region in anti-
body-bound PrP (57). Further, binding of a PrPSc-specific
antibody to an epitope in residues 187–206 (58) could be ex-
plained by a change in loop conformation exposing Phe198
during misfolding. The changes in the S1-HA and HB-HC
connecting loops identified in the middle- and low-pH simu-
lations expose Met residues (Met205 and Met213 are exposed
by S1-HA loop movement, and Met206 is exposed by HB-
HC loop movement). In vivo, exposure of these residues
could lead to oxidation, which has been related to destabili-
zation and conversion of PrPC by MD simulation (59) and
experiment (60).Local pH-dependent changes around histidine
residues
Significant pH-dependent changes in polar interactions are
described in the Supporting Material. Here, we will focus
on differences involving the four His residues in the globular
domain (Fig. 1 C), as these may be involved in triggering
pH-dependent misfolding. His140 is predicted to have the
highest pKa (61) and is therefore likely the first to be proton-
ated when the pH decreases. At neutral and low pH, His140
was positioned predominantly out into solvent. At middle
pH, a permanent salt bridge was formed with Asp147
(100% of the time in all simulations). This salt bridge was
also found in previous MD simulations (61,62), but did
not affect the Asp147-Arg151 salt bridge that may stabilize
HA (63). His155 and His177 were predominantly solvent-
exposed at all pH regimes, in agreement with the structures
obtained from NMR data measured at pH 7.0 (26) and 4.5
(7). In two middle-pH simulations, the His177 side chain
formed a stable salt bridge (with Asp178 in simulation 3,
and with Glu211 in simulation 4).Biophysical Journal 99(7) 2289–2298His187 is positioned between HB and HC and the
C-terminal part of HA. Because of its buried location, it is
likely to be the last His to become protonated as the pH
decreases (61). At neutral pH, His187 donated a hydrogen
bond to the backbone carbonyl of Arg156 for approximately
one-third of the time, thereby linking HA and HB. This
interaction is also found in the crystal structures of human
recPrP (55,57) and in a fraction (20%) of the deposited
NMR structures (7,26). However, it never formed in the
middle- or low-pH simulations. Protonation of His187 may
thus explain the triggering of instability and conformational
change caused by lowering of pH. Of interest, mutation of
His187 to Arg is linked to familial CJD (64). In all middle-
pH simulations, His187 formed a stable salt bridge with
Asp202 within 5 ns of simulation (Fig. 3 C). This interaction
was made possible by the dislocation of Phe198, and once the
His187-Asp202 salt bridge was formed, it prevented Phe198
from moving back to its original position.Early misfolding at the middle-pH regime
The fifth simulation at middle pH showed significant confor-
mational changes similar to those found previously in low-
pH simulations and described as a potential conversion to
a PrPSc-like conformation (29,30). Conversion and aggrega-
tion of recPrP was recently induced solely by lowering the
pH to 4.0 and gentle rotation (24), and the simulation pre-
sented here provides insight into the detailed molecular
mechanism of early misfolding that is required for aggrega-
tion at such conditions. The simulation is characterized by
the addition of an extra strand onto the native b-sheet
(Fig. 4), exposure of hydrophobic surfaces (Fig. 4), and
significant movement of HA away from the HB-HC core
(Figs. 3 A and 4 A).
The first event was the addition of an extra strand to the
native b-sheet. From 1.65 ns, a b-bridge (two main-chain
hydrogen bonds) formed betweenAla120 and Leu130. An addi-
tional hydrogen bond formed between the amide ofVal122 and
the carbonyl of Tyr128 during extended periods (from 6.2 ns),
defining residues 120–122 as ab-strand interactingwithS1.At
certain periods (e.g., 33.2–36.3 ns), this strand extended to
Gly123. Between 40.5 and 42.6 ns, the beginnings of a second
additional strand (residues 115–117)were observed (Fig. 4A).
Furthermore, significant protection to hydrogen exchange in
the 117–133 region was recently observed in hamster PrPSc
(65) and in fibrils formed from PrP 23–144 (66). In this partic-
ular simulation, further extension of the native sheet was
blocked by the formation of a short a-helical segment (resi-
dues 106–114), which overlaps with the region that was indi-
cated to have a-helical character based on theoretical
predictions (67), simulation (68), and experiment (69). The
formation of sheet-like conformations in previous simulations
(27,30), aswell as amyloid formation of peptides spanning this
region (69–71), reflects the propensity of the N-terminal
region of PrP to further extend the currently observed b-sheet.
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FIGURE 4 Early misfolding of PrP as observed at the middle-pH regime, simulation 5. (A) Snapshots from the trajectory at the indicated time points.
The backbone is colored as in Fig. 1, with new strands in dark red (for online version). Relevant residues and hydrogen bonds are shown. For clarity, residues
90–105 are omitted. (B) Secondary structure analysis with all residues participating in hydrogen bonding marked as part of the secondary structure element.
(C) Selected contacts over time. (D) Number of hydrophobic atom-atom contacts over time between residues 137,139,141 and 205,209,213. At 0 ns there are
45 contacts; at 50 ns none remain.
pH-Induced Changes in the Prion Protein 2295The misfolding trajectory showed significant exposure of
hydrophobic residues (Fig. 2 C). An initial increase in the
solvent accessibility of the hydrophobic core (~120 A˚2within
1 ns) was due to the expulsion of Phe198 from the hydro-
phobic core. A second increase (by another ~230 A˚2)
occurred between 15 and 23 ns and was related to the loss
of hydrophobic contacts between the S1-HA loop and HC
(Fig. 3 B). An initial decline to <10 hydrophobic atom-
atom contacts occurred around 16 ns (Fig. 4D). This decline
started with Ile139 moving away from HC (losing all hydro-
phobic contacts from 15.6 ns) while Pro137 and Phe141 were
still in contact. Thereafter, hydrophobic contacts further
declined until no stable contacts remained.
In conjunction with the loss of hydrophobic contacts
between the S1-HA loop and HC, HA moved away from
the HB-HC core. After 15.75 ns, the hydrogen bond between
Tyr149 and Asp202 broke (Fig. 4 C), and simultaneously resi-
dues 153–156 became a-helical. These events marked the
first shift of the N-terminal end of HA away from HC. After
20.5 ns the Arg156-Glu196 salt bridge broke, allowing for
greater movement of HA that resulted in the N-terminal
end moving further out into solvent. Shortly after theArg156-Glu196 salt bridge broke, Arg156 formed a stable salt
bridge with Glu152 (Fig. 4 C). Arg156 occasionally formed
a salt bridge with Asp202 also, an interaction that has also
been observed in replica-exchange MD simulations (50).Misfolding and aggregation
In this work we identified specific conformational changes
and areas of instability related to a decrease in pH. These
changes may be related to the misfolding and subsequent
aggregation of PrP, which in turn results in neurotoxicity
and formation of an infectious particle. Three main changes
stand out: 1), extension of the native sheet into the flexible
N-terminal domain; 2), movement of HA and the preceding
loop out into solvent; and 3), rearrangement of the loop
between HB and HC. The first two are related to regions
involved in the binding interface between PrPC and PrPSc:
residues 98–110 and 136–140. Residues 136–140 were first
predicted to form a strand based on MD simulations (28),
and this region is important for oligomerization (29). New
experimental data on amyloid formed from human PrP
23–144 (66) also support our proposal that these two regionsBiophysical Journal 99(7) 2289–2298
2296 van der Kamp and Daggettare brought together upon aggregation, as in the spiral
protofibril models based on PrP conformations from MD
simulations and in agreement with a range of experimental
data (12,29,31,54). The misfolded conformation at middle
pH identified here also fits into this general model, which
may represent a toxic and soluble oligomeric state (72). In
this conformation, the three helices are still largely intact,
whereas refolding of HB and HCmay be required for forma-
tion of the final amyloid fibril (24,73,74), although many
experimental findings argue against that. Such restructuring
would likely happen later in the aggregation process
(75,76), and the pH-dependent changes in the HB-HC
loop indicate that restructuring may start there, as proposed
previously (55,77).CONCLUSIONS
Extensive simulations of human PrP at three different pH
regimes revealed detailed conformational and dynamical
changes that can occur in low pH environments. The most
significant change was the displacement of HA away from
the HB-HC core. This movement was related to changes
in the preceding loop that exposed a significant hydrophobic
area. These changes, which can be directly related to exper-
imental results, favor aggregation of PrP. Further changes
involved extension of the native b-sheet and conformational
changes in the loop connecting HB and HC. The detailed
changes in conformation and dynamics of the prion protein
in response to lowering of the pH described in this study are
not only consistent with experimental data, they also
provide insight into the mechanism of pH-induced misfold-
ing. This information is being exploited for drug develop-
ment, as aggregation of misfolded proteins is a crucial
stage in the development of prion disease.SUPPORTING MATERIAL
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